Sponsors, CROs, regulators, sites and opinion leaders have discussed the pros and cons of a risk-based approach to field monitoring for years. The pharmaceutical industry always sought guidance from the FDA, and different approaches for reviewing data collected by sites.
Improving diversity, education, and advancement in studies: a look at the IDEAS initiative.
The Avoca Group's "2012 Industry Survey," sponsors and service providers were asked to share their experiences with strategic partnerships.
Industry news focusing on the people and organizations who work in the clinical trials profession.
Public's view of clinical research has improved during the past five years, CISCRP survey reveals.
There is great optimism that new genomic discoveries and technical advances will reduce the cost and time of moving important new therapies for cancer and other critical diseases from laboratory to patients.
Workers from France, Italy, and Spain account for more than a third of total staff at the European Medicines Agency, plus around 68% of agency staff members are women, according to new statistics.
Medidata Minute Episode 1: Harlan Krumholz, Professor of Medicine, Epidemiology, and Public Health, Yale University School of Medicine discusses the role of data analysis in improving healthcare outcomes for patients
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
